APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ifosfamide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ifosfamide Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchIfosfamide Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ifosfamide Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Ifosfamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ifosfamide Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ifosfamide Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Ifosfamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ifosfamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ifosfamide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ifosfamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ifosfamide include Taisheng Zhiyao, TEVA, Qilu Pharma, Mylan, Hengrui Medicine, Pfizer, Ruiying Pharma, Jinrui Pharma and Quanxing Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ifosfamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ifosfamide market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ifosfamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ifosfamide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ifosfamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ifosfamide Market by Company

Taisheng Zhiyao

TEVA

Qilu Pharma

Mylan

Hengrui Medicine

Pfizer

Ruiying Pharma

Jinrui Pharma

Quanxing Pharma

Lingnan Pharma

Baxter

GLS Pharma

Ifosfamide Segment by Type

0.5g/Vial

1g/Vial

Ifosfamide Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Ifosfamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ifosfamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ifosfamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ifosfamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ifosfamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ifosfamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.5g/Vial Table 2. Major Company of 1g/Vial Table 3. Global Ifosfamide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ifosfamide Sales by Type (2021-2026) & (kg) Table 5. Global Ifosfamide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ifosfamide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ifosfamide Sales Market Share in Value by Type (2021-2026) Table 8. Global Ifosfamide Price by Type (2021-2026) & (US$/kg) Table 9. Global Ifosfamide Sales by Type (2027-2032) & (kg) Table 10. Global Ifosfamide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ifosfamide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ifosfamide Sales Market Share in Value by Type (2027-2032) Table 13. Global Ifosfamide Price by Type (2027-2032) & (US$/kg) Table 14. North America Ifosfamide Sales by Type (2021-2026) & (kg) Table 15. North America Ifosfamide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ifosfamide Sales by Type (2021-2026) & (kg) Table 17. Europe Ifosfamide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ifosfamide Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Ifosfamide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ifosfamide Sales by Type (2021-2026) & (kg) Table 21. Latin America Ifosfamide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ifosfamide Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Ifosfamide Sales by Type (2021-2026) & (US$ Million) Table 24. Ifosfamide Industry Trends Table 25. Ifosfamide Industry Drivers Table 26. Ifosfamide Industry Opportunities and Challenges Table 27. Ifosfamide Industry Restraints Table 28. Global Ifosfamide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ifosfamide Revenue Market Share by Company (2021-2026) Table 30. Global Ifosfamide Sales by Company (2021-2026) & (kg) Table 31. Global Ifosfamide Sales Share by Company (2021-2026) Table 32. Global Ifosfamide Market Price by Company (2021-2026) & (US$/kg) Table 33. Global Ifosfamide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ifosfamide Major Company Production Sites and Headquarters Table 35. Global Ifosfamide Company, Product Type & Application Table 36. Global Ifosfamide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ifosfamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ifosfamide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ifosfamide Sales by Region (2021-2026) & (kg) Table 41. Global Ifosfamide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ifosfamide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ifosfamide Sales Market Share in Value by Region (2021-2026) Table 44. Global Ifosfamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 45. Global Ifosfamide Sales by Region (2027-2032) & (kg) Table 46. Global Ifosfamide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ifosfamide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ifosfamide Sales Market Share in Value by Region (2027-2032) Table 49. Global Ifosfamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 50. Global Ifosfamide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ifosfamide Sales by Application (2021-2026) & (kg) Table 52. Global Ifosfamide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ifosfamide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ifosfamide Sales Market Share in Value by Application (2021-2026) Table 55. Global Ifosfamide Price by Application (2021-2026) & (US$/kg) Table 56. Global Ifosfamide Sales by Application (2027-2032) & (kg) Table 57. Global Ifosfamide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ifosfamide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ifosfamide Sales Market Share in Value by Application (2027-2032) Table 60. Global Ifosfamide Price by Application (2027-2032) & (US$/kg) Table 61. North America Ifosfamide Sales by Application (2021-2026) & (kg) Table 62. North America Ifosfamide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ifosfamide Sales by Application (2021-2026) & (kg) Table 64. Europe Ifosfamide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ifosfamide Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Ifosfamide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ifosfamide Sales by Application (2021-2026) & (kg) Table 68. Latin America Ifosfamide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ifosfamide Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Ifosfamide Sales by Application (2021-2026) & (US$ Million) Table 71. Taisheng Zhiyao Company Information Table 72. Taisheng Zhiyao Business Overview Table 73. Taisheng Zhiyao Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Taisheng Zhiyao Ifosfamide Product Portfolio Table 75. Taisheng Zhiyao Recent Development Table 76. TEVA Company Information Table 77. TEVA Business Overview Table 78. TEVA Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. TEVA Ifosfamide Product Portfolio Table 80. TEVA Recent Development Table 81. Qilu Pharma Company Information Table 82. Qilu Pharma Business Overview Table 83. Qilu Pharma Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Qilu Pharma Ifosfamide Product Portfolio Table 85. Qilu Pharma Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Mylan Ifosfamide Product Portfolio Table 90. Mylan Recent Development Table 91. Hengrui Medicine Company Information Table 92. Hengrui Medicine Business Overview Table 93. Hengrui Medicine Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Hengrui Medicine Ifosfamide Product Portfolio Table 95. Hengrui Medicine Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Pfizer Ifosfamide Product Portfolio Table 100. Pfizer Recent Development Table 101. Ruiying Pharma Company Information Table 102. Ruiying Pharma Business Overview Table 103. Ruiying Pharma Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Ruiying Pharma Ifosfamide Product Portfolio Table 105. Ruiying Pharma Recent Development Table 106. Jinrui Pharma Company Information Table 107. Jinrui Pharma Business Overview Table 108. Jinrui Pharma Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Jinrui Pharma Ifosfamide Product Portfolio Table 110. Jinrui Pharma Recent Development Table 111. Quanxing Pharma Company Information Table 112. Quanxing Pharma Business Overview Table 113. Quanxing Pharma Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 114. Quanxing Pharma Ifosfamide Product Portfolio Table 115. Quanxing Pharma Recent Development Table 116. Lingnan Pharma Company Information Table 117. Lingnan Pharma Business Overview Table 118. Lingnan Pharma Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 119. Lingnan Pharma Ifosfamide Product Portfolio Table 120. Lingnan Pharma Recent Development Table 121. Baxter Company Information Table 122. Baxter Business Overview Table 123. Baxter Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 124. Baxter Ifosfamide Product Portfolio Table 125. Baxter Recent Development Table 126. GLS Pharma Company Information Table 127. GLS Pharma Business Overview Table 128. GLS Pharma Ifosfamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 129. GLS Pharma Ifosfamide Product Portfolio Table 130. GLS Pharma Recent Development Table 131. North America Ifosfamide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 132. North America Ifosfamide Sales by Country (2021-2026) & (kg) Table 133. North America Ifosfamide Sales Market Share by Country (2021-2026) Table 134. North America Ifosfamide Sales Forecast by Country (2027-2032) & (kg) Table 135. North America Ifosfamide Sales Market Share Forecast by Country (2027-2032) Table 136. North America Ifosfamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Ifosfamide Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Ifosfamide Market Share by Country (2021-2026) Table 139. North America Ifosfamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Ifosfamide Market Share Forecast by Country (2027-2032) Table 141. Europe Ifosfamide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 142. Europe Ifosfamide Sales by Country (2021-2026) & (kg) Table 143. Europe Ifosfamide Sales Market Share by Country (2021-2026) Table 144. Europe Ifosfamide Sales Forecast by Country (2027-2032) & (kg) Table 145. Europe Ifosfamide Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Ifosfamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Ifosfamide Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Ifosfamide Market Share by Country (2021-2026) Table 149. Europe Ifosfamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Ifosfamide Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Ifosfamide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Ifosfamide Sales by Country (2021-2026) & (kg) Table 153. Asia-Pacific Ifosfamide Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Ifosfamide Sales Forecast by Country (2027-2032) & (kg) Table 155. Asia-Pacific Ifosfamide Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Ifosfamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Ifosfamide Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Ifosfamide Market Share by Country (2021-2026) Table 159. Asia-Pacific Ifosfamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Ifosfamide Market Share Forecast by Country (2027-2032) Table 161. Latin America Ifosfamide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 162. Latin America Ifosfamide Sales by Country (2021-2026) & (kg) Table 163. Latin America Ifosfamide Sales Market Share by Country (2021-2026) Table 164. Latin America Ifosfamide Sales Forecast by Country (2027-2032) & (kg) Table 165. Latin America Ifosfamide Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Ifosfamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Ifosfamide Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Ifosfamide Market Share by Country (2021-2026) Table 169. Latin America Ifosfamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Ifosfamide Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Ifosfamide Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Ifosfamide Sales by Country (2021-2026) & (kg) Table 173. Middle East and Africa Ifosfamide Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Ifosfamide Sales Forecast by Country (2027-2032) & (kg) Table 175. Middle East and Africa Ifosfamide Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Ifosfamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Ifosfamide Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Ifosfamide Market Share by Country (2021-2026) Table 179. Middle East and Africa Ifosfamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Ifosfamide Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Ifosfamide Distributors List Table 184. Ifosfamide Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Ifosfamide Image Figure 2. Global Ifosfamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ifosfamide Market Size (2021-2032) & (US$ Million) Figure 4. Global Ifosfamide Sales (2021-2032) & (kg) Figure 5. 0.5g/Vial Image Figure 6. Global 0.5g/Vial Sales YoY Growth (2021-2032) & (kg) Figure 7. 1g/Vial Image Figure 8. Global 1g/Vial Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Ifosfamide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ifosfamide Market Share by Type 2025 VS 2032 Figure 11. North America Ifosfamide Sales Market Share in Volume by Type in 2025 Figure 12. North America Ifosfamide Sales Market Share in Value by Type in 2025 Figure 13. Europe Ifosfamide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ifosfamide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ifosfamide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ifosfamide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ifosfamide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ifosfamide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ifosfamide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ifosfamide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ifosfamide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacies Image Figure 24. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 25. Online Pharmacies Image Figure 26. Global Online Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (kg) Figure 29. Global Ifosfamide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Ifosfamide Market Share by Application 2025 VS 2032 Figure 31. North America Ifosfamide Sales Market Share in Volume by Application in 2025 Figure 32. North America Ifosfamide Sales Market Share in Value by Application in 2025 Figure 33. Europe Ifosfamide Sales Market Share in Volume by Application in 2025 Figure 34. Europe Ifosfamide Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Ifosfamide Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Ifosfamide Sales Market Share in Value by Application in 2025 Figure 37. Latin America Ifosfamide Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Ifosfamide Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Ifosfamide Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Ifosfamide Sales Market Share in Value by Application in 2025 Figure 41. North America Ifosfamide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 42. North America Ifosfamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Ifosfamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ifosfamide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 46. Europe Ifosfamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Ifosfamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ifosfamide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 50. Asia-Pacific Ifosfamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Ifosfamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ifosfamide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 54. Latin America Ifosfamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Ifosfamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ifosfamide Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 58. Middle East and Africa Ifosfamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ifosfamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Ifosfamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Ifosfamide Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Ifosfamide Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5g/Vial
  • 1g/Vial
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Taisheng Zhiyao
  • TEVA
  • Qilu Pharma
  • Mylan
  • Hengrui Medicine
  • Pfizer
  • Ruiying Pharma
  • Jinrui Pharma
  • Quanxing Pharma
  • Lingnan Pharma
  • Baxter
  • GLS Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ifosfamide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ifosfamide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ifosfamide Market by Type
  6. 1.3.1 0.5g/Vial
  7. 1.3.2 1g/Vial
  8. 1.4 Global Ifosfamide Market Size by Type
  9. 1.4.1 Global Ifosfamide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ifosfamide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ifosfamide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ifosfamide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ifosfamide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ifosfamide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ifosfamide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ifosfamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ifosfamide Industry Trends
  2. 2.2 Ifosfamide Industry Drivers
  3. 2.3 Ifosfamide Industry Opportunities and Challenges
  4. 2.4 Ifosfamide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ifosfamide Revenue (2021-2026)
  2. 3.2 Global Top Players by Ifosfamide Sales (2021-2026)
  3. 3.3 Global Top Players by Ifosfamide Price (2021-2026)
  4. 3.4 Global Ifosfamide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ifosfamide Major Company Production Sites & Headquarters
  6. 3.6 Global Ifosfamide Company, Product Type & Application
  7. 3.7 Global Ifosfamide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ifosfamide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ifosfamide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ifosfamide Tier 1, Tier 2, and Tier 3
4 Ifosfamide Regional Status and Outlook
  1. 4.1 Global Ifosfamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ifosfamide Historic Market Size by Region
  3. 4.2.1 Global Ifosfamide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ifosfamide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ifosfamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ifosfamide Forecasted Market Size by Region
  7. 4.3.1 Global Ifosfamide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ifosfamide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ifosfamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ifosfamide by Application
  1. 5.1 Ifosfamide Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Ifosfamide Market Size by Application
  6. 5.2.1 Global Ifosfamide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ifosfamide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ifosfamide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ifosfamide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ifosfamide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ifosfamide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ifosfamide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ifosfamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Taisheng Zhiyao
  2. 6.1.1 Taisheng Zhiyao Company Information
  3. 6.1.2 Taisheng Zhiyao Business Overview
  4. 6.1.3 Taisheng Zhiyao Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Taisheng Zhiyao Ifosfamide Product Portfolio
  6. 6.1.5 Taisheng Zhiyao Recent Developments
  7. 6.2 TEVA
  8. 6.2.1 TEVA Company Information
  9. 6.2.2 TEVA Business Overview
  10. 6.2.3 TEVA Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 TEVA Ifosfamide Product Portfolio
  12. 6.2.5 TEVA Recent Developments
  13. 6.3 Qilu Pharma
  14. 6.3.1 Qilu Pharma Company Information
  15. 6.3.2 Qilu Pharma Business Overview
  16. 6.3.3 Qilu Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Pharma Ifosfamide Product Portfolio
  18. 6.3.5 Qilu Pharma Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Ifosfamide Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Hengrui Medicine
  26. 6.5.1 Hengrui Medicine Company Information
  27. 6.5.2 Hengrui Medicine Business Overview
  28. 6.5.3 Hengrui Medicine Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hengrui Medicine Ifosfamide Product Portfolio
  30. 6.5.5 Hengrui Medicine Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Ifosfamide Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Ruiying Pharma
  38. 6.7.1 Ruiying Pharma Company Information
  39. 6.7.2 Ruiying Pharma Business Overview
  40. 6.7.3 Ruiying Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ruiying Pharma Ifosfamide Product Portfolio
  42. 6.7.5 Ruiying Pharma Recent Developments
  43. 6.8 Jinrui Pharma
  44. 6.8.1 Jinrui Pharma Company Information
  45. 6.8.2 Jinrui Pharma Business Overview
  46. 6.8.3 Jinrui Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jinrui Pharma Ifosfamide Product Portfolio
  48. 6.8.5 Jinrui Pharma Recent Developments
  49. 6.9 Quanxing Pharma
  50. 6.9.1 Quanxing Pharma Company Information
  51. 6.9.2 Quanxing Pharma Business Overview
  52. 6.9.3 Quanxing Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Quanxing Pharma Ifosfamide Product Portfolio
  54. 6.9.5 Quanxing Pharma Recent Developments
  55. 6.10 Lingnan Pharma
  56. 6.10.1 Lingnan Pharma Company Information
  57. 6.10.2 Lingnan Pharma Business Overview
  58. 6.10.3 Lingnan Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lingnan Pharma Ifosfamide Product Portfolio
  60. 6.10.5 Lingnan Pharma Recent Developments
  61. 6.11 Baxter
  62. 6.11.1 Baxter Company Information
  63. 6.11.2 Baxter Business Overview
  64. 6.11.3 Baxter Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Baxter Ifosfamide Product Portfolio
  66. 6.11.5 Baxter Recent Developments
  67. 6.12 GLS Pharma
  68. 6.12.1 GLS Pharma Company Information
  69. 6.12.2 GLS Pharma Business Overview
  70. 6.12.3 GLS Pharma Ifosfamide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GLS Pharma Ifosfamide Product Portfolio
  72. 6.12.5 GLS Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Ifosfamide Sales by Country
  2. 7.1.1 North America Ifosfamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ifosfamide Sales by Country (2021-2026)
  4. 7.1.3 North America Ifosfamide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ifosfamide Market Size by Country
  6. 7.2.1 North America Ifosfamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ifosfamide Market Size by Country (2021-2026)
  8. 7.2.3 North America Ifosfamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ifosfamide Sales by Country
  2. 8.1.1 Europe Ifosfamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ifosfamide Sales by Country (2021-2026)
  4. 8.1.3 Europe Ifosfamide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ifosfamide Market Size by Country
  6. 8.2.1 Europe Ifosfamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ifosfamide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ifosfamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ifosfamide Sales by Country
  2. 9.1.1 Asia-Pacific Ifosfamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ifosfamide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ifosfamide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ifosfamide Market Size by Country
  6. 9.2.1 Asia-Pacific Ifosfamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ifosfamide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ifosfamide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ifosfamide Sales by Country
  2. 10.1.1 South America Ifosfamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ifosfamide Sales by Country (2021-2026)
  4. 10.1.3 South America Ifosfamide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ifosfamide Market Size by Country
  6. 10.2.1 South America Ifosfamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ifosfamide Market Size by Country (2021-2026)
  8. 10.2.3 South America Ifosfamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ifosfamide Sales by Country
  2. 11.1.1 Middle East and Africa Ifosfamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ifosfamide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ifosfamide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ifosfamide Market Size by Country
  6. 11.2.1 Middle East and Africa Ifosfamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ifosfamide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ifosfamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ifosfamide Value Chain Analysis
  2. 12.1.1 Ifosfamide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ifosfamide Production Mode & Process
  7. 12.2 Ifosfamide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ifosfamide Distributors
  10. 12.2.3 Ifosfamide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst